ArticleBioscience reports2020

TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.

Yi Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.